Skip to content

Positive Lifestyles Using Safety

Positive Lifestyles Using Safety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00836290
Acronym
Project PLUS
Enrollment
90
Registered
2009-02-04
Start date
2008-01-31
Completion date
2010-08-31
Last updated
2015-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, HIV Infections

Keywords

risk reduction, HIV prevention, HIV education, HIV Seronegativity

Brief summary

Project PLUS tests an HIV risk reduction/adherence behavioral intervention with HIV-infected individuals in Connecticut prisons. Participants are randomly assigned to one of three groups: prior to release from incarceration (Group 1), after release from incarceration (Group 2), and treatment-as-usual (Group 3). We hypothesize that the intervention groups (Groups 1 & 2) will demonstrate significantly greater knowledge regarding drug- and sex- related HIV risk behavior and HIV medication adherence, greater motivation to reduce HIV risk behavior and improve HIV medication adherence, and enhanced skills for engaging in HIV risk reduction behavior and HIV medication adherence vs. the treatment-as-usual group. We will also compare these outcomes between Groups 1 and 2.

Detailed description

Project PLUS is an HIV risk reduction/Highly Active Antiretroviral Therapy (HAART) adherence behavioral intervention for persons being released from prisons in Connecticut. The intervention is delivered one-on-one to HIV-infected individuals prior to release from incarceration (Group 1) vs. after release from incarceration (Group 2) vs. treatment as usual (Group 3). The primary hypothesis is that the intervention groups (Groups 1 & 2) will demonstrate significantly greater reduction in rates of HIV sexual and drug risk behaviors and a significantly greater increase in HAART adherence compared to Group 3 participants at 4 months following release from prison. (However, those in Group 3 may come back to participate in the educational sessions, as non-study participants, after their participation has been completed). Based on the IMB model of health behavior change, the primary outcomes of interest are HIV risk reduction knowledge, motivation, behavioral skills (Fisher & Fisher, 1992) and specific event-level partner-by-partner drug and sex risk outcomes including the frequency of unprotected sex episodes across different partners categorized by perceived HIV-status of each partner, numbers of different sexual partners, changes in the frequency of condom use, changes in reported adherence to HIV medication, and changes in reported drug use episodes across different partners categorized by perceived HIV-status of each partner. Additional outcomes of interest include greater knowledge regarding drug- and sex- related HIV risk behaviors and HAART adherence, greater motivation to reduce HIV risk behaviors and improve HAART adherence, enhanced skills for engaging in HIV risk reduction behaviors and HAART adherence. A comparison between Groups 1 & 2 has never been examined, so an important part of this study is to explore this comparison.

Interventions

BEHAVIORALPre-Release (Group 1)

Participants in the pre-release intervention group will receive four sessions in the four-week period prior to release and will receive a comprehensive booster session four weeks after release.

BEHAVIORALPost-release (Group 2)

Participants in the post-release intervention group will receive one comprehensive introductory session four weeks before release and four sessions during the four-week period after release.

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Yale AIDS Program
CollaboratorUNKNOWN
AIDS Project Hartford
CollaboratorINDUSTRY
Connecticut State, Department of Correction
CollaboratorUNKNOWN
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Are 18 years of age or older * Meet DSM-IV criteria for opioid-dependence * Are scheduled to be released from prison within the next 30 days * Are confirmed to be HIV-infected * Report drug- or sex-related HIV risk behavior prior to incarceration * Are willing to provide locator information * Able to read and understand the questionnaires and consent form * No minimum duration of incarceration * Available for the full duration of the study with no anticipated circumstances impeding participation (e.g., pending court case or warrant).

Exclusion criteria

* Have an untreated bipolar or psychotic disorder * Suicidal or homicidal ideation

Design outcomes

Primary

MeasureTime frame
Frequency of unprotected sex episodes across different partners categorized by perceived HIV-status of each partnerPre-release, Day of Release, 1-mo ff-up, 3-mo ff-up
Numbers of different sexual partnersPre-release, Day of Release, 1-mo ff-up, 3-mo ff-up
Changes in the frequency of condom use reportedPre-release, Day of Release, 1-mo ff-up, 3-mo ff-up
Changes in reported HIV medication adherencePre-release, Day of Release, 1-mo ff-up, 3-mo ff-up
Changes in reported drug use episodes across different partners categorized by perceived HIV-status of each partnerPre-release, Day of Release, 1-mo ff-up, 3-mo ff-up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026